Aeromics
Manufacturing · Connecticut, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
470 James St Ste 7, New Haven, Connectic...Phone Number
(203) 208-8864Website
www.aeromics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Aeromics
Aeromics, Inc. is a clinical-stage pharmaceutical company focused on developing innovative therapeutics targeting aquaporin-4 (AQP4) to control edema in patients suffering from severe ischemic stroke and other conditions. Their lead product, AER-271, aims to prevent brain swelling following ischemic events, significantly improving patient outcomes and recovery times. The company is currently conducting Phase 1 clinical trials to assess the safety and tolerability of AER-271, with plans for a Phase II efficacy trial. Aeromics is dedicated to addressing critical medical needs in neurology through advanced understanding of water physiology.Explore more
Aeromics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Aeromics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Aeromics launches new products
Earning: See what the market has to say on Aeromics recently announced quarterly report
Check if Aeromics has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Aeromics is spiking on competitors!
Website visits: Recent activity has been detected on your website
Click to see if Aeromics had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Aeromics
Funding: Get notified immidiatlly once Aeromics has new funding data
Aeromics, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Aeromics
Compare insights from companies similar to Aeromics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Aeromics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Aeromics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Aeromics.
Aeromics financials insights
Gather financial insights about Aeromics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2009
Grant
$2.3M
2014
Private Equity
$1.3M
2016
Debt
$1.9M
2017
Debt
$1.5M
Private Equity
$6.4M
Aeromics Tech Stack
A closer look at the technologies used by Aeromics
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Aeromics
Sign Up For FreeTo access detailed company insights
Aeromics, Inc. is a clinical-stage pharmaceutical company focused on developing innovative therapeutics targeting aquaporin-4 (AQP4) to control edema in patients suffering from severe ischemic stroke and other conditions. Their lead product, AER-271, aims to prevent brain swelling following ischemic events, significantly improving patient outcomes... Read More
